Brain circuits behind sundowning and day–night rhythm problems in Alzheimer’s

The circuit basis of sundowning-related circadian dysfunction in Alzheimer's disease and Alzheimer's disease-related dementias

['FUNDING_R01'] · UNIVERSITY OF WYOMING · NIH-11177628

This work looks at how changes in brain clock pathways may cause sundowning and disrupted daily rhythms in people with Alzheimer’s disease.

Quick facts

Phase['FUNDING_R01']
Study typeNih_funding
SexAll
SponsorUNIVERSITY OF WYOMING (nih funded)
Locations1 site (LARAMIE, UNITED STATES)
Trial IDNIH-11177628 on ClinicalTrials.gov

What this research studies

The team uses mouse models that mimic Alzheimer’s to map the brain clock (the SCN) and its connections to regions controlling body temperature, activity, and aggression. They will alter specific circuit nodes to see whether disrupting them produces late-afternoon or evening agitation and wandering similar to sundowning. By linking circuit changes to time-of-day patterns of behavior, the researchers aim to identify biological targets that could guide new treatments.

Who could benefit from this research

Good fit: People with Alzheimer’s disease or related dementias who experience late-afternoon or evening agitation, aggression, or wandering (sundowning) would be the most relevant group for future therapies guided by this research.

Not a fit: People without Alzheimer’s or without time-of-day agitation and sleep–wake problems are unlikely to gain direct benefits from this project in the near term.

Why it matters

Potential benefit: If successful, this work could identify brain targets for treatments that reduce sundowning and improve sleep–wake patterns in people with Alzheimer’s.

How similar studies have performed: Prior animal studies show the SCN and downstream pathways influence activity and aggression rhythms, but applying these findings directly to sundowning is a newer and less-tested approach.

Where this research is happening

LARAMIE, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Conditions: Alzheimer disease dementia

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.